Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

BRCA2 and Smad3 synergize in regulation of gene transcription

Abstract

Smad3 is an essential component in the intracellular signaling of transforming growth factor-β (TGFβ), which is a potent inhibitor of tumor cell proliferation. BRCA2 is a tumor suppressor involved in early onset of breast, ovarian and prostate cancer. Both Smad3 and BRCA2 possess transcription activation domains. Here, we show that Smad3 and BRCA2 interact functionally and physically. We found that BRCA2 forms a complex with Smad3 in vitro and in vivo, and that both MH1 and MH2 domains of Smad3 contribute to the interaction. TGFβ1 stimulates interaction of endogenous Smad3 and BRCA2 in non-transfected cells. BRCA2 co-activates Smad3-dependent transcriptional activation of luciferase reporter and expression of plasminogen activator inhibitor-1 (PAI-1). Smad3 increases the transcriptional activity of BRCA2 fused to the DNA-binding domain (DBD) of Gal4, and reciprocally, BRCA2 co-activates DBD-Gal4-Smad3. Thus, our results show that BRCA2 and Smad3 form a complex and synergize in regulation of transcription.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Akiyoshi S, Inoue H, Hanai J, Kusanagi K, Nemoto N, Miyazono K, Kawabata M . 1999 J. Biol. Chem. 274: 35269–35277

  • Connor F, Bertwistle D, Mee PJ, Ross GM, Swift S, Grigorieva E, Tybulewicz VL, Ashwoth A . 1997 Nat. Genet. 17: 423–430

  • Chen X, Rubock MJ, Whitman M . 1996 Nature 383: 691–696

  • de Caestecker M, Piek E, Roberts AB . 2000 J. Natl. Cancer Inst. 92: 1388–1402

  • Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier J-M . 1998 EMBO J. 17: 3091–3100

  • Fuks F, Milner J, Kouzarides T . 1998 Oncogene 17: 2531–2534

  • Hanahan D, Weinberg R . 2000 Cell 100: 57–70

  • Hanai J, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo WH, Imamura T, Ishidou Y, Fukuchi M, Shi MJ, Stavnezer J, Kawabata M, Miyazono K, Ito Y . 1999 J. Biol. Chem. 274: 31577–31582

  • Hofmann W, Schlag PM . 2000 J.Cancer Res. Oncol. 126: 487–496

  • Hua X, Liu X, Ansari DO, Lodish HF . 1998 Genes Dev. 12: 3084–3095

  • Itoh S, Ericsson J, Nishikawa J, Heldin C-H, ten Dijke P . 2000 Nucleic Acids Res. 28: 4291–4298

  • Jonk LJ, Itoh S, Heldin C-H, ten Dijke P, Kruijer W . 1998 J. Biol. Chem. 273: 21145–21152

  • Kurokawa M, Mitani K, Irie K, Matsuyama T, Takahashi T, Chiba S, Yazaki Y, Matsumoto K, Hirai H . 1998 Nature 394: 92–96

  • Laiho M, Saksela O, Keski-Oja J . 1987 J. Biol. Chem. 262: 17467–17474

  • Liberati NT, Datto MB, Frederick JP, Shen X, Wong C, Rougier-Chapman EM, Wang X-F . 1999 Proc. Natl. Acad. Sci. USA 96: 4844–4849

  • Ludwig T, Chapman DL, Papaioannou VE, Efstratiadis A . 1997 Genes Dev. 11: 1226–1241

  • Lund LR, Riccio A, Andreasen PA, Nielsen LS, Kristensen P, Laiho M, Saksela O, Blasi F, Dano K . 1987 EMBO J. 6: 1281–1286

  • Marmorstein LY, Ouchi T, Aaronson A . 1998 Proc. Natl. Acad. Sci. USA. 95: 13869–13874

  • Milner J, Ponder B, Hughes-Davies L, Seltmann M, Kouzarides T . 1997 Nature 386: 772–773

  • Miyazono K, ten Dijke P, Heldin C-H . 2000 Adv. Immun. 75: 115–157

  • Moustakas A, Kardassis D . 1998 Proc. Natl. Acad. Sci. USA 95: 6733–6738

  • Nordling M, Karsson P, Wahlstrom J, Engwall Y, Wallgren A, Martinsson T . 1998 Cancer Res. 58: 1372–1375

  • Pardali E, Xie X-Q, Itoh S, Konstantinos A, Panagiotis T, Heldin C-H, ten Dijke P, Gundström T, Sideras P . 2000 J. Biol. Chem. 275: 3552–3560

  • Piek E, Heldin C-H, ten Dijke P . 1999 FASEB J. 13: 2105–2124

  • Scully R, Livingston DM . 2000 Nature 408: 429–432

  • Spain BH, Larson CJ, Shihabuddin LS, Gage FH, Verma I . 1999 Proc. Natl. Acad., Sci. USA 96: 13920–13925

  • Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K . 1999 Science 286: 771–774

  • Sun Y, Liu X, Eaton EN, Lane WS, Lodish HF, Weinberg RA . 1999 Mol. Cell 4: 499–509

  • Vindevoghel L, Lechleider RJ, Kon A, de Caestecker MP, Uitto J, Roberts AB, Mauviel A . 1998 Proc. Natl. Acad. Sci. USA 95: 14769–14774

  • Yakymovych I, ten Dijke P, Heldin C-H, Souchelnytskyi S . 2001 FASEB J. 15: 553–555

  • Zawel L, LeDai J, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, Kern S . 1998 Mol. Cell 1: 611–617

  • Zhang Y, Feng X-H, Derynck R . 1998 Nature 394: 909–913

Download references

Acknowledgements

We are thankful to Johan Ericsson for valuable discussions, and to Francois Fuks, Tony Kouzarides and Inder Verma for BRCA2 constructs. This work was supported in part by grants of the Royal Swedish Academy of Sciences, the INSERM/MFR/VR and the EU-program on angiogenesis to Serhiy Souchelnytskyi. Takashi Kanamoto was supported by the Swedish Foundation for International Cooperation in Research and Higher Education (STINT).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Serhiy Souchelnytskyi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Preobrazhenska, O., Yakymovych, M., Kanamoto, T. et al. BRCA2 and Smad3 synergize in regulation of gene transcription. Oncogene 21, 5660–5664 (2002). https://doi.org/10.1038/sj.onc.1205732

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205732

Keywords

This article is cited by

Search

Quick links